mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma

Area of Science:

• Hepatology
• Virology
• Molecular Biology

Background:

• Chronic hepatitis B virus (HBV) infection remains a significant global health challenge.
• Current treatments control HBV but struggle to eliminate the cccDNA pool for a functional cure.
• The mammalian target of rapamycin (mTOR) pathway regulates crucial cellular processes like growth, apoptosis, and metabolism.

Purpose of the Study:

• To systematically review the role of the mTOR signaling pathway in the HBV life cycle.
• To elucidate the impact of mTOR activation on the pathogenesis and clinical progression of chronic HBV infection.
• To identify mTOR as a potential therapeutic target for controlling HBV infection and its complications.

Main Methods:

• Literature review of studies investigating mTOR signaling in HBV infection.
• Analysis of evidence linking HBV replication to mTOR pathway activation.
• Examination of mTOR's role in HBV-associated hepatocellular carcinoma development.

Main Results:

• HBV infection activates the mTOR pathway, suggesting viral hijacking for replication.
• mTOR plays a critical role in cellular processes exploited by HBV.
• Aberrant mTOR activation is linked to hepatocellular carcinoma, a common progression from chronic hepatitis B.

Conclusions:

• The mTOR signaling pathway is integral to HBV pathogenesis and viral replication.
• Targeting the mTOR pathway presents a promising strategy for managing chronic hepatitis B.
• Further research into mTOR's specific mechanisms in HBV infection is warranted for therapeutic development.